• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo.

作者信息

Billington C J, Briggs J E, Link J G, Levine A S

机构信息

Department of Research, Minneapolis Veterans Administration Medical Center, Minnesota.

出版信息

Am J Physiol. 1991 Aug;261(2 Pt 2):R501-7. doi: 10.1152/ajpregu.1991.261.2.R501.

DOI:10.1152/ajpregu.1991.261.2.R501
PMID:1877708
Abstract

Our aims were to further characterize the stimulatory effect of glucagon on brown fat and to test the hypothesis that physiological levels of hyperglucagonemia would stimulate brown fat thermogenesis. In the first set of experiments, glucagon (1 mg/kg sc twice daily) or vehicle control was administered three times in 26 h. This large dose of glucagon produced increases in GDP binding to brown fat mitochondria. In addition, Scatchard analysis indicated a glucagon-induced increase in number of GDP binding sites without evidence for alteration in binding site affinity. No consistent increase in brown fat mitochondrial GDP binding was produced 2 h after a single injection of glucagon (1 mg/kg). In the second set of experiments, glucagon was administered intraperitoneally by constant osmotic minipump infusion. Glucagon in a dose of 150 micrograms.kg-1.day-1 for 5 days produced significant increases in GDP binding to brown fat mitochondria, whereas glucagon serum levels were increased but stayed within the usual physiological range. A larger dose of glucagon administered by constant infusion virtually eliminated body weight gain over 7 days while significantly increasing nucleotide binding (GDP) to brown fat mitochondria. An important role for glucagon in thermogenic regulation is suggested.

摘要

相似文献

1
Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo.
Am J Physiol. 1991 Aug;261(2 Pt 2):R501-7. doi: 10.1152/ajpregu.1991.261.2.R501.
2
Glucagon stimulation of brown adipose tissue growth and thermogenesis.胰高血糖素对棕色脂肪组织生长和产热的刺激作用。
Am J Physiol. 1987 Jan;252(1 Pt 2):R160-5. doi: 10.1152/ajpregu.1987.252.1.R160.
3
Nicotine increases thermogenesis in brown adipose tissue in rats.
Pharmacol Biochem Behav. 1988 Jan;29(1):33-7. doi: 10.1016/0091-3057(88)90269-9.
4
Corticosterone decreases nonshivering thermogenesis and increases lipid storage in brown adipose tissue.皮质酮会降低非颤抖性产热,并增加棕色脂肪组织中的脂质储存。
Am J Physiol. 1995 Jan;268(1 Pt 2):R183-91. doi: 10.1152/ajpregu.1995.268.1.R183.
5
The effects of 2-deoxy-D-glucose and sympathetic denervation of brown fat GDP binding in Sprague-Dawley rats.
Life Sci. 1990;46(14):1037-44. doi: 10.1016/0024-3205(90)90028-p.
6
Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells.
Am J Physiol. 1998 Nov;275(5):R1674-82. doi: 10.1152/ajpregu.1998.275.5.R1674.
7
Activation of brown fat thermogenesis in response to central injection of corticotropin releasing hormone in the rat.
Neuropharmacology. 1987 Aug;26(8):1217-21. doi: 10.1016/0028-3908(87)90272-3.
8
GDP binding to rat brown fat mitochondria: effects of thyroxine at different ambient temperatures.GDP与大鼠棕色脂肪线粒体的结合:不同环境温度下甲状腺素的影响。
Am J Physiol. 1981 Sep;241(3):C134-9. doi: 10.1152/ajpcell.1981.241.3.C134.
9
Rapid changes in number of GDP binding sites on brown adipose tissue mitochondria.棕色脂肪组织线粒体上GDP结合位点数量的快速变化。
Am J Physiol. 1986 Aug;251(2 Pt 1):E192-5. doi: 10.1152/ajpendo.1986.251.2.E192.
10
Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.
Am J Physiol. 1991 Feb;260(2 Pt 2):R321-7. doi: 10.1152/ajpregu.1991.260.2.R321.

引用本文的文献

1
GLP-1R/GCGR dual agonism dissipates hepatic steatosis to restore insulin sensitivity and rescue pancreatic β-cell function in obese male mice.胰高血糖素样肽-1受体/胰高血糖素受体双重激动作用可消除肥胖雄性小鼠的肝脂肪变性,恢复胰岛素敏感性并挽救胰腺β细胞功能。
Nat Commun. 2025 May 21;16(1):4714. doi: 10.1038/s41467-025-59773-4.
2
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data.用于治疗2型糖尿病和肥胖症的双靶点和三靶点肠道肽激动剂即将问世。临床前和临床数据概述
Curr Obes Rep. 2025 Apr 11;14(1):34. doi: 10.1007/s13679-025-00623-1.
3
Transforming obesity: The advancement of multi-receptor drugs.
转变肥胖:多受体药物的进步。
Cell. 2024 Jul 25;187(15):3829-3853. doi: 10.1016/j.cell.2024.06.003.
4
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges.用于代谢性疾病的多激动剂药物疗法:希望与新挑战
Drugs. 2024 Feb;84(2):127-148. doi: 10.1007/s40265-023-01982-6. Epub 2023 Dec 21.
5
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets.基于肠促胰岛素受体的双重和三重激动剂在胰岛中的作用机制。
Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E595-E609. doi: 10.1152/ajpendo.00236.2023. Epub 2023 Sep 20.
6
The role of hormones in sepsis: an integrated overview with a focus on mitochondrial and immune cell dysfunction.激素在脓毒症中的作用:关注线粒体和免疫细胞功能障碍的综合概述。
Clin Sci (Lond). 2023 May 5;137(9):707-725. doi: 10.1042/CS20220709.
7
The acute effect of glucagon on components of energy balance and glucose homoeostasis in adults without diabetes: a systematic review and meta-analysis.成人非糖尿病患者胰高血糖素对能量平衡和血糖稳态成分的急性作用:系统评价和荟萃分析。
Int J Obes (Lond). 2022 Nov;46(11):1948-1959. doi: 10.1038/s41366-022-01223-y. Epub 2022 Sep 19.
8
High Protein Diet Feeding Aggravates Hyperaminoacidemia in Mice Deficient in Proglucagon-Derived Peptides.高蛋白饮食喂养加重了前胰高血糖素衍生肽缺乏小鼠的高氨基酸血症。
Nutrients. 2022 Feb 25;14(5):975. doi: 10.3390/nu14050975.
9
The incretin/glucagon system as a target for pharmacotherapy of obesity.肠促胰岛素/胰高血糖素系统作为肥胖症药物治疗的靶点。
Obes Rev. 2022 Feb;23(2):e13372. doi: 10.1111/obr.13372. Epub 2021 Oct 28.
10
Glucagon's Metabolic Action in Health and Disease.胰高血糖素在健康和疾病中的代谢作用。
Compr Physiol. 2021 Apr 1;11(2):1759-1783. doi: 10.1002/cphy.c200013.